[1]
Lopes-Pacheco M, Silva PL, Cruz FF, et al. Pathogenesis of multiple organ injury in COVID-19 and potential therapeutic strategies. Front Physiol 2021; 12: 593223.
[http://dx.doi.org/10.3389/fphys.2021.593223] [PMID: 33584343]
[http://dx.doi.org/10.3389/fphys.2021.593223] [PMID: 33584343]
[2]
CDC. Long COVID or Post-COVID Conditions 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html#:~:text=Some%20people%2C%20especially%20those%20who,kidney%2C%20skin%2C%20and%20brain
[3]
Bhalerao A, Raut S, Noorani B, Mancuso S, Cucullo L. Molecular mechanisms of multi-organ failure in COVID-19 and potential of stem cell therapy. Cells 2021; 10(11): 2878.
[http://dx.doi.org/10.3390/cells10112878] [PMID: 34831101]
[http://dx.doi.org/10.3390/cells10112878] [PMID: 34831101]
[4]
Ioganathan S, Kuppusamy M, Wankhar W, et al. Angiotensinconverting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes. Respir Physiol Neurobiol 2021; 283: 103548.
[http://dx.doi.org/10.1016/j.resp.2020.103548] [PMID: 32956843]
[http://dx.doi.org/10.1016/j.resp.2020.103548] [PMID: 32956843]
[5]
O’Connor RJ, Preston N, Parkin A, et al. The COVID‐19 yorkshire rehabilitation scale (C19‐YRS): Application and psychometric analysis in a post‐COVID‐19 syndrome cohort. J Med Virol 2022; 94(3): 1027-34.
[http://dx.doi.org/10.1002/jmv.27415] [PMID: 34676578]
[http://dx.doi.org/10.1002/jmv.27415] [PMID: 34676578]
[6]
Umakanth M, Suganthan N. Unusual manifestations of dengue fever: A review on expanded dengue syndrome. Cureus 2020; 12(9): e10678.
[http://dx.doi.org/10.7759/cureus.10678] [PMID: 33133844]
[http://dx.doi.org/10.7759/cureus.10678] [PMID: 33133844]
[7]
Mallhi TH, Yusra HK, Nida T, Raja AA. Expanded Dengue Syndrome. Springer 2021.
[http://dx.doi.org/10.1007/978-981-15-7337-8]
[http://dx.doi.org/10.1007/978-981-15-7337-8]
[8]
Louis TJ, Qasem A, Abdelli LS, Naser SA. Extra-pulmonary complications in SARS-CoV-2 infection: A comprehensive multi organ-system review. Microorganisms 2022; 10(1): 153.
[http://dx.doi.org/10.3390/microorganisms10010153] [PMID: 35056603]
[http://dx.doi.org/10.3390/microorganisms10010153] [PMID: 35056603]
[9]
Ning Q, Wu D, Wang X, et al. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduct Target Ther 2022; 7(1): 57.
[http://dx.doi.org/10.1038/s41392-022-00907-1] [PMID: 35197452]
[http://dx.doi.org/10.1038/s41392-022-00907-1] [PMID: 35197452]
[10]
Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020; 26(7): 1017-32.
[http://dx.doi.org/10.1038/s41591-020-0968-3] [PMID: 32651579]
[http://dx.doi.org/10.1038/s41591-020-0968-3] [PMID: 32651579]
[11]
Zheng KI, Feng G, Liu WY, Targher G, Byrne CD, Zheng MH. Extrapulmonary complications of COVID‐19: A multisystem disease? J Med Virol 2021; 93(1): 323-35.
[http://dx.doi.org/10.1002/jmv.26294] [PMID: 32648973]
[http://dx.doi.org/10.1002/jmv.26294] [PMID: 32648973]
[12]
Mustafa ZU, Maqbool F, Wahid M, et al. Short-term adverse effects of COVID-19 vaccines after the first, second, and booster doses: A cross-sectional survey from Punjab, Pakistan, and the implications. Rev Soc Bras Med Trop 2023; 56: e0044-2023.
[http://dx.doi.org/10.1590/0037-8682-0044-2023] [PMID: 37283345]
[http://dx.doi.org/10.1590/0037-8682-0044-2023] [PMID: 37283345]
[13]
Mallhi TH, Khan YH, Butt MH, et al. Surveillance of side effects after two doses of COVID-19 vaccines among patients with comorbid conditions: A sub-cohort analysis from Saudi Arabia. Medicina 2022; 58(12): 1799.
[http://dx.doi.org/10.3390/medicina58121799] [PMID: 36557002]
[http://dx.doi.org/10.3390/medicina58121799] [PMID: 36557002]
[14]
Mohamed MS, Mohamed AO, Alenazy R, et al. A first report on side-effects of COVID-19 vaccines among general population in Sudan: A cross-sectional analysis. Vaccines 2023; 11(2): 315.
[http://dx.doi.org/10.3390/vaccines11020315] [PMID: 36851192]
[http://dx.doi.org/10.3390/vaccines11020315] [PMID: 36851192]
[15]
Alzarea AI, Khan YH, Alatawi AD, et al. Surveillance of post-vaccination side effects of COVID-19 vaccines among Saudi population: a real-world estimation of safety profile. Vaccines 2022; 10(6): 924.
[http://dx.doi.org/10.3390/vaccines10060924] [PMID: 35746532]
[http://dx.doi.org/10.3390/vaccines10060924] [PMID: 35746532]
[16]
Amjad Z, Maryam I, Munir M, et al. COVID-19 vaccines status, acceptance and hesitancy among maintenance hemodialysis patients: A cross-sectional study and the implications for Pakistan and beyond. Vaccines 2023; 11(5): 904.
[http://dx.doi.org/10.3390/vaccines11050904] [PMID: 37243008]
[http://dx.doi.org/10.3390/vaccines11050904] [PMID: 37243008]